Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
36 /100
MEDIUM RISK
Score updated Oct 27, 2026

COGT — Cogent Biosciences, Inc. Dilution Risk Tracker

Track COGT dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track COGT — Get alerts when the score changes →

As of October 27, 2026, Cogent Biosciences, Inc. (COGT) has a DilutionWatch DilutionScore of 36/100, rated MEDIUM dilution risk. Cogent Biosciences, Inc. has a market capitalization of $5.46B, 173.52M shares outstanding, 309 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
32
💰 Cash Runway
65
📊 Float Risk
7
⚠️ Warrant Exposure
15
🔄 Convertible Debt
15

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 7%
💰 Capital Raise model 15%
• Under 12 months cash (9mo)
🔔 Track COGT — Get forecast alerts →

Market Data

Market Cap$5.46B
Shares Outstanding173.52M
Float160.86M
Cash$187.87M
Debt$44.25M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore36/100DilutionWatch score record
Shares Outstanding173.52MVerified float table or market cache
Public Float160.86MVerified float table or market cache
Market Cap$5.46BMarket data cache
Cash Runway9.2 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 2.

Recent SEC source mix: XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

COGT SEC Filing Activity — Last 12 Months

Shares outstanding reported by COGT on the cover page of its latest 10-K/10-Q: 173.52M as of August 06, 2026.

DilutionWatch recorded 5 registration or prospectus documents for COGT (the filings through which shares are offered) in the last 12 months. Full filing list on SEC EDGAR →

FormWhat it isFilingsMost recent
424B5prospectus supplement (ATM / shelf takedown)5Aug 10, 2026
8-Kcurrent report (material event)10Aug 10, 2026
10-Qquarterly report1May 05, 2026
DEF 14Aproxy statement1Apr 23, 2026
SC 13Gpassive >5% holder filing1Jul 31, 2026
4insider transaction9Oct 05, 2026
3initial insider ownership2May 14, 2026

Institutional Holdings

QoQ: ↑ 18.2% shares (2026Q1 vs prior)
309 institutional holders · 209.90M shares
#1 FMR LLC 23.12M shares
#2 BlackRock, Inc. 16.05M shares
#3 VANGUARD CAPITAL MANAGEMENT LLC 13.79M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest19.66M
Days to Cover8.9
% of Float12.2%
FINRA data as of Oct 15, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-02-17
xbrl XBRL CONVERTIBLE 2020-03-26
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual COGT Dilution Snapshot

Cogent Biosciences, Inc. (COGT) has a DilutionScore of 36/100, rated Medium dilution risk. Score date: October 27, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

COGT's DilutionScore is currently 36/100 (Medium risk), with 2 score changes tracked over 89 days. The score improved from 27/100 (Medium risk).

Period Score Risk Level Duration
Aug 22 – Oct 27, 202636/100MEDIUM67 days
Aug 14 – Aug 21, 202627/100MEDIUM7 days
Jul 30 – Aug 13, 202624/100LOW15 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

COGT shares outstanding have increased 5.3% from 162.31M (Mar 2026) to 170.87M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 10, 2026170.87M160.86M▲ 0.02%
May 09, 2026170.87M160.83M▲ 0.03%
May 08, 2026170.87M160.79M▲ 6.09%
May 03, 2026170.80M151.55M▲ 0.38%
Mar 20, 2026162.31M150.97M▲ 0.06%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track COGT Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment COGT files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking COGT — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,566+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for COGT
COGT FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.